After years of caution, pharma advertisers are embracing influencer marketing

After years of caution, pharma advertisers are embracing influencer marketing

Pharma clients used to be wary of the creator economy. Why are they now throwing caution to the wind?

Additional coverage:

• Lawyers for the U.S. Justice Department and Google yesterday began their closing arguments in an ongoing antitrust trial, with the day covering a number of key topics core to the case including search market landscape, search quality, alternatives options for users.
• On the last day of the IAB’s four-day NewFronts event, social platforms like Meta and TikTok pitched their short-form video offerings to advertisers — and the latter social media platform addressed the Senate's recent ruling to ban it in the U.S.
• Google's Privacy Sandbox needs some work before publishers say they're willing to dedicate time and attention to testing further.
• Measurement and attribution are common pain points for advertisers looking to track campaign performance in retail media. They're pain points that CVS Media Exchange, CVS’s retail media arm, is aiming to solve to help it stand out in an increasingly crowded landscape.
• Connected TV and digital out-of-home are playing a bigger role in upcoming elections and politics — especially for smaller agencies looking to place clients' dollars.
• Our most-read story this week: Walmart and Roblox are teaming up to make virtual e-commerce a reality